Enhancing Pharmaceutical Product Quality With a Comprehensive Corrective and Preventive Actions (CAPA) Framework:...

Area of Science:

• Pharmaceutical Quality Assurance
• Regulatory Compliance
• Quality Management Systems

Background:

• Corrective and Preventive Actions (CAPA) are fundamental to pharmaceutical quality assurance (QA).
• CAPA systems are integral to the Quality Management System (QMS), supporting continuous improvement.
• They ensure product quality, safety, and adherence to regulatory standards.

Purpose of the Study:

• To explore the comprehensive role of CAPA in pharmaceutical manufacturing.
• To detail the structured approach of CAPA in identifying, resolving, and preventing quality issues.
• To examine regulatory expectations and methodologies that enhance CAPA effectiveness.

Main Methods:

• Review of CAPA principles and their application in pharmaceutical manufacturing.
• Analysis of CAPA phases: correction, corrective action (CA), and preventive action (PA).
• Discussion of root cause analysis, regulatory guidelines (FDA, ICH Q10), and the 8D problem-solving methodology.

Main Results:

• CAPA functions as a dual-loop mechanism, both reactive and proactive.
• Effective CAPA requires immediate corrections and long-term preventive strategies.
• Integration of data analysis and process enhancements is crucial for a comprehensive CAPA plan.

Conclusions:

• Robust CAPA implementation is essential for maintaining high standards in pharmaceutical manufacturing.
• Adherence to regulatory expectations and structured problem-solving enhance CAPA efficacy.
• Continuous improvement of CAPA processes contributes to overall pharmaceutical quality and safety.